About
Contact & Profiles
A5098775487
Research Areas
- Herpesvirus Infections and Treatments
- Oral Health Pathology and Treatment
- Ocular Diseases and Behçet’s Syndrome
Ocular Immunology and Uveitis Foundation
2024
Massachusetts Eye Research and Surgery Institute
2024
Purpose To evaluate outcomes of intravenous (IV) tocilizumab (TCZ) in patients with pars planitis refractory to conventional immunomodulatory therapy and anti-tumor necrosis factor (TNF) alpha agents.
10.1080/09273948.2024.2354751
article
EN
Ocular Immunology and Inflammation
2024-05-23
Coming Soon ...